Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.45)
# 3,604
Out of 5,139 analysts
177
Total ratings
45.33%
Success rate
-1.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $6.47 | +23.65% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $167.16 | +22.64% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $96.76 | +20.92% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $87.31 | +8.81% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $535.00 | +21.50% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $12.39 | -3.15% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $143.37 | -33.74% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $79.00 | +7.59% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $43.39 | -65.43% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $287.70 | +19.22% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.77 | +690.96% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $20.11 | +138.69% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $84.35 | +20.92% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $88.07 | -34.14% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $17.16 | +16.55% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $69.54 | +88.38% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $121.76 | +9.23% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $363.78 | -39.52% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $103.00 | +266.99% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $6.47
Upside: +23.65%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $167.16
Upside: +22.64%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $96.76
Upside: +20.92%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $87.31
Upside: +8.81%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $535.00
Upside: +21.50%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $12.39
Upside: -3.15%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $143.37
Upside: -33.74%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $79.00
Upside: +7.59%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $43.39
Upside: -65.43%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $287.70
Upside: +19.22%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.77
Upside: +690.96%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $20.11
Upside: +138.69%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $84.35
Upside: +20.92%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $88.07
Upside: -34.14%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $17.16
Upside: +16.55%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $69.54
Upside: +88.38%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $121.76
Upside: +9.23%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $363.78
Upside: -39.52%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $103.00
Upside: +266.99%